Research
Hormonal
Postoperative weight regain (WR) affects 20-30% of patients after bariatric surgery.
Clinicians should be aware that a significant portion of bariatric surgery patients may experience weight regain.
StrongSupportsmedium confidence
Bariatric surgery, while effective for severe obesity, is often challenged by postoperative weight regain (WR), affecting 20-30% of patients.
Why this rating
The claim is based on a narrative review of existing literature.
Source
Weight Recidivism After Bariatric Surgery: A Narrative Review
Qilin Cao et al. · The American Surgeon · 2025
DOI 10.1177/00031348251337161
reviewCited 7×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →